U.S. Markets open in 2 hrs 12 mins

Reata Pharmaceuticals, Inc. (RETA)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
113.37+2.27 (+2.04%)
At close: 4:00PM EST

113.00 -0.37 (-0.33%)
Before hours: 7:13AM EST

Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Currency in USD

Valuation Measures

Premium required to access annual data
Premium required to access monthly data
Subscribe to Premium to download historical data
We’re sorry, we weren’t able to find any data.
Please try reloading the page.

Trading Information

Stock Price History

Beta (5Y Monthly) 1.57
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 3257.96
52 Week Low 388.17
50-Day Moving Average 3121.45
200-Day Moving Average 3126.08

Share Statistics

Avg Vol (3 month) 3357.76k
Avg Vol (10 day) 3293.96k
Shares Outstanding 531.07M
Float 25.39M
% Held by Insiders 14.77%
% Held by Institutions 171.49%
Shares Short (Dec 30, 2020) 43.12M
Short Ratio (Dec 30, 2020) 46.95
Short % of Float (Dec 30, 2020) 413.30%
Short % of Shares Outstanding (Dec 30, 2020) 48.65%
Shares Short (prior month Nov 29, 2020) 43.21M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2019
Most Recent Quarter (mrq)Sep 29, 2020


Profit Margin 0.00%
Operating Margin (ttm)-4,080.69%

Management Effectiveness

Return on Assets (ttm)-49.70%
Return on Equity (ttm)-623.06%

Income Statement

Revenue (ttm)8.5M
Revenue Per Share (ttm)0.26
Quarterly Revenue Growth (yoy)-83.00%
Gross Profit (ttm)-225.99M
EBITDA -345.65M
Net Income Avi to Common (ttm)-368.92M
Diluted EPS (ttm)-11.19
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)578.26M
Total Cash Per Share (mrq)17.07
Total Debt (mrq)1.27M
Total Debt/Equity (mrq)0.68
Current Ratio (mrq)12.98
Book Value Per Share (mrq)5.49

Cash Flow Statement

Operating Cash Flow (ttm)-426.58M
Levered Free Cash Flow (ttm)-212.38M